Drug delivery, disposition and dynamics (D4)

Drug Delivery, Disposition and Dynamics

The Drug delivery, disposition and dynamics (D4) research teams within the Monash Institute of Pharmaceutical Sciences (MIPS) are designing and developing the next generation of drug delivery systems and anti-infective agents to enhance medicine effectiveness and patient treatment.

See the latest news

Monash University to accelerate the development of novel medicine designed to save women’s lives in child birth in collaboration with Janssen

Postpartum haemorrhage (PPH), a condition of excessive blood loss after birth, is the world’s leading cause of maternal mortality, resulting in an estimated 60,000 deaths per year in resource-limited countries. A novel form of oxytocin, an

4 August, 2020

MIPS researchers PIK out a new drug target to reduce heart attacks

Researchers from Monash University’s Institute of Pharmaceutical Sciences (MIPS) together with other Monash and international collaborators have discovered a new target for drugs that could potentially prevent heart attacks and strokes by

31 July, 2020

MIPS researchers shine a light on the gap in national manufacturing capability of COVID vaccine

Monash University researchers have been featured in Australian media outlets as the global race to produce a vaccine against COVID-19 speeds up.

24 July, 2020

Nutrition breakthrough: Australian scientists mimic the behaviour of cow and human milk fats during digestion

In an important step forward for infant milk substitutes and nutrition, researchers from Monash University’s Institute of Pharmaceutical Sciences (MIPS) have shown that simple fat mixtures can imitate the behaviour of vastly more complex

17 July, 2020

Australian scientists use nanotechnologies to engineer low-cost immunotherapies

Researchers from Monash University’s Institute of Pharmaceutical Sciences (MIPS) are paving the way for accessible and affordable cancer treatment by using powerful nanoscale tools to overcome the high costs and long lead-times associated

16 July, 2020

Melbourne researchers use cutting-edge technology to produce three new COVID-19 vaccine candidates

Monash University researchers have produced the first known mRNA COVID-19 vaccine candidates in Australia using an advanced technological approach capable of generating vaccines ready for human testing in record time.

2 July, 2020

Professor Nicolas Voelcker named Australian Academy of Technology and Engineering Fellow

Professor Nicolas Voelcker from the Drug Delivery Disposition & Dynamics Theme at the Monash Institute of Pharmaceutical Sciences (MIPS) has been named an Australian Academy of Technology and Engineering Fellow.

23 October, 2019

A/Prof Joe Nicolazzo receives IMPACT grant from FIGHTMND

FightMND has announced a major funding commitment to advance research into Motor Neurone Disease as the fight to find effective treatments and a cure for the disease continues.

16 October, 2019

MIPS maintains top score in 2018 ERA rankings

The Monash Institute of Pharmaceutical Sciences has again received excellent results in the latest Excellence in Research for Australia (ERA) rankings.

17 September, 2019